ArticleOncoimmunology

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy.

Hélène Roussel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.